Back
AnGes, Inc. Vs. United Therapeutics Corp. Industry Stock Comparison
Sell
41
AMGXF
AnGes, Inc.
Last Price:
$0.36
Seasonality Move:
-7.2%
Buy
65
UTHR
United Therapeutics Corp.
Last Price:
$564.50
Seasonality Move:
4.56%
Sell
41
AnGes, Inc. (AMGXF)
is a Sell
Is AnGes, Inc. a Buy, Sell or Hold?
-
The current AnGes, Inc. [AMGXF] share price is $0.36. The Score for AMGXF is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
AMGXF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
United Therapeutics Corp. (UTHR)
is a Buy
Is United Therapeutics Corp. a Buy, Sell or Hold?
-
The current United Therapeutics Corp. [UTHR] share price is $564.81. The Score for UTHR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMGXF Stock Price Chart
What is AnGes, Inc.'s stock price today?
-
The AnGes, Inc. share price today is $0.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMGXF is experiencing slight buying pressure.
UTHR Stock Price Chart
What is United Therapeutics Corp.'s stock price today?
-
The United Therapeutics Corp. share price today is $564.81The current trend is moderately bullish and UTHR is experiencing slight buying pressure.
AMGXF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 0 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.36) | Buy |
| Bollinger Bands (100): | (0.36 - 0.36) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.09 | Buy |
| Relative Strength Index (14 RSI): | 59.88 | Buy |
| Chaikin Money Flow: | 14395 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (503.16 - 558.5) | Buy |
| Bollinger Bands (100): | (466.31 - 523.25) | Buy |
AMGXF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Sell |
| 20-day SMA: | 0.36 | Sell |
| 50-day SMA: | 0.36 | Sell |
| 200-day SMA: | 0.36 | Sell |
| 8-day EMA: | 0.35 | Buy |
| 20-day EMA: | 0.29 | Buy |
| 50-day EMA: | 0.17 | Buy |
| 200-day EMA: | 0.05 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 555.65 | Buy |
| 20-day SMA: | 538.96 | Buy |
| 50-day SMA: | 504.75 | Buy |
| 200-day SMA: | 427.15 | Buy |
| 8-day EMA: | 558.98 | Buy |
| 20-day EMA: | 540.23 | Buy |
| 50-day EMA: | 515.7 | Buy |
| 200-day EMA: | 447.12 | Buy |
AnGes, Inc. Earnings Growth & AMGXF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United Therapeutics Corp. Earnings Growth & UTHR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $1.56 per share, an increase this year of $1.59 per share, and an increase next year of $5.20 per share.
AnGes, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||